pfizer glp 1 oral Woke up to news that just halted their GLP-1 candidate after a liver injury was reported in Phase 1. Two thoughts immediately came to mind: 1. This is exactly why Pfizer punts on one oral

The upper arm (posterior tricep area) is the third approved site, but it generally shows the most variability, particularly in individuals with lower body fat percentages

Patients who discontinue treatment regain approximately two-thirds of weight loss within one year

Collectively, these data suggest that GLP-1RA-related hypoglycemia is severe, despite the low risk of death

stop at the first warning sign

There have been postmarketing reports of acute renal failure and worsening of chronic renal failure, which may sometimes require hemodialysis [see Warnings and Precautions (5.5) and Adverse Reactions (6.2)]

Endocrinology 15512801290